"Situados en la calle Arturo Soria 103 - 105. El centro pone a disposición de sus pacientes un equipamiento sanitario completo sobre el que nuestros equipos asistenciales desarrollan su labor para ofrecer la mejor atención a 400.000 pacientes al año."

During the past decade, Hospital Vithas Nuestra Señora de America conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Vithas Nuestra Señora de America" are "Idiopathic Hypersomnia" (1 trials), "Narcolepsy Type 1 (NT1)" (1 trials), "Narcolepsy Type 2 (NT2)" (1 trials) and "Narcolepsy With Cataplexy" (1 trials). Many other conditions were trialed in "Hospital Vithas Nuestra Señora de America" in a lesser frequency.

Most popular intervention types in "Hospital Vithas Nuestra Señora de America" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "JZP-258" (2 trials), "Placebo" (2 trials), "Placebo Oral Solution" (1 trials) and "TAK-994" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Vithas Nuestra Señora de America" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Vithas Nuestra Señora de America". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Vithas Nuestra Señora de America, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Vithas Nuestra Señora de America, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".